The University of Southern Mississippi

The Aquila Digital Community
Doctoral Projects

Fall 12-2016

Reducing Hypotension in Elective Cesarean
Section Patients with Administration of
Ondansetron Prior to Spinal Anesthesia: A
Retrospective Chart Analysis
Linsey Erin Phipps
The University of Southern Mississippi

Follow this and additional works at: https://aquila.usm.edu/dnp_capstone
Part of the Maternal, Child Health and Neonatal Nursing Commons, Other Nursing Commons,
and the Perioperative, Operating Room and Surgical Nursing Commons
Recommended Citation
Phipps, Linsey Erin, "Reducing Hypotension in Elective Cesarean Section Patients with Administration of Ondansetron Prior to
Spinal Anesthesia: A Retrospective Chart Analysis" (2016). Doctoral Projects. 55.
https://aquila.usm.edu/dnp_capstone/55

This Doctoral Nursing Capstone Project is brought to you for free and open access by The Aquila Digital Community. It has been accepted for inclusion
in Doctoral Projects by an authorized administrator of The Aquila Digital Community. For more information, please contact
Joshua.Cromwell@usm.edu.

REDUCING HYPOTENSION IN ELECTIVE CESAREAN SECTION PATIENTS
WITH ADMINISTRATION OF ONDANSETRON PRIOR TO SPINAL
ANESTHESIA: A RETROSPECTIVE CHART ANALYSIS
by
Linsey Erin Phipps

A Capstone Project
Submitted to the Graduate School
and the Department of Advanced Practice
at The University of Southern Mississippi
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Nursing Practice
Approved:
________________________________________________
Dr. Bonnie Harbaugh, Committee Chair
Professor, Systems Leadership and Health Outcomes
________________________________________________
Dr. SatAnanda Hayden, Committee Member
Assistant Professor, Systems Leadership and Health Outcomes
________________________________________________
Dr. Michong Rayborn, Committee Member
Assistant Professor, Advanced Practice
________________________________________________
Dr. Karen S. Coats
Dean of the Graduate School
December 2016

COPYRIGHT BY

Linsey Erin Phipps

2016

Published by the Graduate School

ABSTRACT
REDUCING HYPOTENSION IN ELECTIVE CESAREAN SECTION PATIENTS
WITH ADMINISTRATION OF ONDANSETRON PRIOR TO SPINAL
ANESTHESIA: A RETROSPECTIVE CHART ANALYSIS
by Linsey Erin Phipps
December 2016
The birth of a child is one of the most memorable moments in a woman’s life, and
many women undergo an elective cesarean section, requiring spinal anesthesia. At this
time, the patient and the unborn child’s well-being become the anesthetist’s main focus.
The ultimate goal of anesthesia providers is to provide the safest care to the patient.
Spinal anesthesia has many benefits, but has a common side effect of hypotension, which
can also result in nausea. Hypotension, dangerous to mother and child, is often treated
with vasopressors, but can also cause nausea, which is treated by the administration of
ondansetron. A retrospective chart review (N=114) was performed to examine if the
administration of ondansetron prior to spinal anesthesia in elective cesarean section
patients reduced the occurrence of hypotension. Inclusion criteria consists of patients
receiving spinal anesthesia for elective cesarean sections, ages 20-40 years, ondansetron
only given prior to spinal anesthesia, ondansetron given in ten minutes or less before
spinal anesthesia and met the American Society of Anesthesiologist’s (ASA) patient
status classification I or II. Exclusion criteria includes patients presenting for cesarean
section with epidural due to failure to progress, ASA patient status classification III, IV
or V, emergent cesarean sections, multiple parities (twins/triplets), > 1,000 ml blood loss,
> 6 mg ondansetron administered, patients presenting with a cardiac history (coronary
ii

artery disease, myocardial infarction, congestive heart failure, murmur, mitral valve
prolapse/regurgitation, dysrhythmias, aortic stenosis/regurgitation) and patients
presenting with preeclampsia. A Chi Square test was performed, which indicated no
significant association between administering ondansetron and the occurrence of
hypotension (df=1, x2 (1) = .035, p= .851). A secondary analysis was performed, which
did show a significant association between administering ondansetron and the reduced
usage of vasopressors to increase blood pressure (df=1, x2(1) = 6.437, p= .011). This
evidence indicates that though ondansetron did not result in reducing hypotension, it did
result in decreasing the amount of vasopressors used to maintain blood pressure, which in
turn decreased vasopressor adverse side effects to mother and unborn child.
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CHAPTER I - INTRODUCTION
When women enter the hospital for an elective cesarean section, they are given
the option of general, spinal, or spinal/epidural combined anesthesia. The risk factors and
benefits of each procedure are explained to the patient by the anesthesia provider. The
primary anesthetic procedure used at this time is spinal anesthesia (Sirajuddin, Abbas,
Murtaza, & Naqvi, 2013). Nagelhout and Plaus (2014) state “single shot spinal anesthesia
is the most common used anesthetic technique for cesarean section deliveries because this
technique offers many distinct advantages” (p. 1142). The advantages of spinal
anesthesia include rapid onset, a more reliable block, and uses less toxic doses of local
anesthetics compared to epidural anesthesia. Though there are many advantages that
come from the use of spinal anesthesia, there are also some disadvantages. A few of the
disadvantages when using spinal anesthesia include a chance of having a failure of the
block, the fixed amount of time that a particular drug is effective, and sympathectomy
with resultant hypotension and bradycardia. Farmawy and Rashad (2013) stated that
hypotension represents the incidence of about 55-100%, making it the most frequent
complication. Adults can walk around with low blood pressure every day, for a pregnant
woman and her unborn child, hypotension needs to be treated. Hypotension in a pregnant
woman can cause unconsciousness, which can lead to aspiration. It may also cause
cardiac issues and decreased perfusion to the unborn child (Nagelhout & Plaus, 2014).
Clinical Question
Does ondansetron, a 5HT3 antagonist used commonly to treat nasusea, help
reduce the hypotension associated with spinal anesthesia in women having a cesarean
section? By understanding the effects ondansetron has on the body, healthcare providers
1

can capitalize on the benefits this medication can bring to pregnant women receiving the
medication before the placement of spinal anesthesia. The use of ondansetron prior to
spinal placement has been shown to reduce the excessive use of fluids and the need to use
vasopressors to combat hypotension during the case (Farmawy & Rashad, 2013).
Reducing the utilization of other medications and multiple bags of fluid will in turn
reduce costs for the hospital and pharmacy. The proposed mechanism of ondansetron is
the antagonism by the 5HT3 receptors in the intracardiac vagal nerve endings in the
Bezold Jarisch reflex (Nagelhout & Plaus, 2014). Understanding the different responses
activated by certain medications help make spinal anesthesia safer for pregnant women.
Studies show that the use of opioid medications cause hypotension and that ondansetron
can assist in reversing the hypotensive response. The opioid pathways in the brain are
crucial in the hypotensive response detected after the 5HT3 antagonist receptor
stimulation. By being more aware of the pain medications given to the patients, a better
understanding of the side effects can be realized, and some may be able to be reversed by
ondansetron.
Whether fluids, vasopressors or ondansetron are used to treat hypotension related
to spinal anesthesia, hypotension must be treated to prevent further deterioration of the
patient. Patient safety is the number one goal during the hospital stay. Evidence must be
used to determine the most appropriate ways to increase patient safety and satisfaction.
Ondansetron could be the most useful and cost effective way to maintain hemodynamics
in pregnant women while undergoing spinal anesthesia.
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Background and Significance/Problem Statement
Spinal anesthesia has the potential to produce several undesirable problems; the
main one being hypotension. Nagelhout and Plaus (2014) state “when spinal anesthesia
is used to produce the T4 (thoracic vertebrae 4) block needed for cesarean section,
hypotension has been shown to occur in up to 80% of patients despite the patient being
placed in left uterine displacement” (p. 1143). Typically, hypotension is treated with
either large amounts of fluid therapy or vasopressors. Fluid therapy has been shown to
provide positive outcomes in helping to reduce hypotension, but it can also lead to fluid
overload and urinary retention. Patients with an underlying history of cardiac issues,
such as congestive heart failure, will be unable to receive the typical one liter of fluid
prior to spinal anesthesia. These patients are at a disadvantage and more prone to
developing severe hypotension.
Ephedrine is the most common vasopressor used to treat maternal hypotension.
Ephedrine is a synthetic, noncatecholamine sympathomimetic drug. Ephedrine is
typically administered in doses ranging from five to twenty-five milligrams intravenously
to treat acute decreases in blood pressure (Nagelhout & Plaus, 2014). According to
Nagelhout and Plaus (2014), the effect of five to ten milligram intravenous doses usually
persists for five minutes and the duration of ephedrine’s cardiovascular effects varies
with each dose. Another drawback to the use of this medication is the possibility of
tachyphylaxis. Tachyphylaxis can occur with repeated small dosing of ephedrine, which
results in a decreased clinical effect after subsequent dosing. The issue of constant
redosing and unreliability of duration of action show the drawbacks of using this
medication to treat maternal hypotension. Nagelhout and Plaus (2014) state “recent
3

evidence suggests that ephedrine may cross the placenta and stimulate fetal β-adrenergic
receptors, resulting in depression of fetal acid –base balance” (p. 1143). This makes its
repeated use less than desirable.
Evidence of Problem/Local Need
Spinal anesthesia causes predictable and controllable physiologic changes that
require minimal intervention if detected early. The spinal anesthetic causes a
sympathetic nerve blockade, which in turn causes vasodilation, decreased venous return
and decreased systemic vascular resistance. The changes that are caused by the
sympathetic blockade in turn change the redistribution of blood and lead to hypotension.
According to Nagelhout and Plaus (2014), “hypotension is immediately relevant to the
perfusion of critical organs such as the heart and brain and is important to all organs in
maintaining near homeostasis” (p. 1083).
When discussing the issue of spinal anesthesia and hypotension with anesthesia
providers, there was a consensus that there is an issue in the obstetric population and a
need to reduce the harmful side effects. In an interview with a local CRNA at my
practice site (July 10, 2015), the issue of hypotension associated with spinal anesthesia
was addressed as well as why he chose to administer ondansetron to help reduce this side
effect. The CRNA stated he started using ondansetron in the obstetric population to help
reduce hypotension after spinal anesthesia after he attended a Continuing Education (CE)
meeting discussing this issue. After learning of its use he brought this information back
to the practice site and started administering it to the obstetric patients receiving elective
cesarean sections and spinal anesthesia. The CRNA stated approximately 70% of the
patients receiving ondansetron required zero or a drastically decreased amount of blood
4

pressure support. Ondansetron, four milligrams, is given usually after the preoperative
interview if the patient is being taken directly back to the operating room. The CRNA
said he has seen a decrease in the amount of vasopressors being used during the
procedure due to the administration of ondansetron prior to spinal anesthesia.
Hypotension after spinal anesthesia for cesarean section patients has been an ongoing
issue for this population, the ability to administer a medication that will help reduce this
side effect and help make it safer for mother and child is of the utmost importance.
Purpose of the Project
The aim of this doctoral project is to examine clinical evidence to support a
practice change to reduce the amount of vasopressors administered to cesarean section
patients receiving spinal anesthesia by administering ondansetron, thereby reducing
hypotension related to this particular population and increasing patient safety. Evidence
of the relationship between the administration of ondansetron prior to spinal anesthesia in
cesarean section patients and reduced hypotension, and decreased use of vasopressors
will be done via a retrospective chart review. As healthcare providers, our duty is to
provide care that is efficient and harmless to our patients. Healthcare providers must
evaluate the medications and procedures used and determine if evidence supports
enhancements in the care the patient receives during their stay. Patients come to the
hospital wanting to feel safe and assume the safest, most current forms of treatment are
being used. Through establishing the evidence linking ondansetron to hypotension, when
administered prior to spinal anesthesia for a cesarean section, a change in current practice
may be indicated. Findings will be presented to key stakeholders in an educational
presentation. The educational presentation will disseminate the evidence of relationship
5

of ondansetron, administered prior to spinal anesthesia in cesarean section patients, to
hypotension, and the use of vasopressors. See Appendix D and E for project logic model
and SWOT analysis.
Theoretical Framework
The theory used that represents the concepts of preventing hypotension related to
spinal anesthesia for a cesarean section is The Theory of Human Caring (Watson, 1979).
This theory incorporates the human being, health, environment, and nursing; the nursing
model is concerned with promoting the patient’s health, preventing illness, caring for the
sick and restoring the patient’s health (Watson, 2008). The healthcare provider uses the
nursing process to evaluate the patient. Care plans are developed to help the healthcare
provider determine individual variables that would be included/examined and what data
will be collected; this is the intervention phase. Evaluation of all data collected and
analyzing the results may likely lead to a new idea regarding the problem. In this theory,
caring is a key component that will result in the promotion of the patient’s health and
satisfaction of their needs. Identifying the problem, building a relationship with the
patient that promotes faith and hope in the provider, discussing the problem and options
with the patient, developing a plan for the patient and the problem, all come together in
covering Watson’s 10 carative factors and make her framework a good fit for this
doctoral project.
Doctor of Nursing Practice Essentials
This doctoral project fulfills and applies the 8 practice essentials of the doctor of
nursing practice essentials. This doctoral project meets all eight essentials (See Appendix
B), but the main essentials addressed are Essential IV and VI. In looking at Essential IV,
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there was a retrospective chart review and de-identified patient data was extracted from
their electronic medical record and protected to avoid ethic/legal issues. Electronic
databases were used for review of literature and to obtain information regarding
ondansetron and spinal anesthesia on cesarean section patients. Essential VI was met by
collaboration with anesthesia providers which is pivotal to bringing about a practice
change. Each provider has vital information and suggestions that can help bring about a
change and help in providing the safest care to the patient population. Another vital
component in collaboration for this project, is that of the Electronic Patient Integrated
Care (EPIC) technology staff and the researcher. Without this collaboration, the
information for the project would not have been available.
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CHAPTER II – REVIEW OF LITERATURE
A literature search was conducted to determine if the incidence of hypotension
with spinal anesthesia is reduced if ondansetron is given prior to the procedure for
women receiving an elective cesarean section. A comprehensive review of literature was
performed. Article inclusion criteria were as follows: 1) articles must relate to spinal
anesthesia and the use of ondansetron, 2) must be written in English 3) searches were
limited to peer-reviewed articles appearing in scholarly journals in the past five years.
The search consisted of multiple databases accessed through USM's online catalog. The
databases used were PubMed, Cochrane, CINAHL with Full Text, and Medline. The
search terms used were ondansetron, hypotension, spinal anesthesia and cesarean
section. One hundred sixty-eight articles were found. Six articles met inclusion criteria.
After an initial review, the final six articles consisted of systematic, meta-analysis and
integrative reviews of control trials. Information from the articles was placed into a
literature matrix. (See Appendix A)
Synthesis of Literature
Spinal anesthesia has become a safe alternative to general anesthesia for surgical
interventions. Though the procedure has many advantages, the disadvantages such as
cardiovascular effects can be detrimental. The most common issues expressed are
hypotension and bradycardia. Spinal anesthesia decreases vascular resistance and
stimulates the Bezold-Jarisch reflex. The responses in turn cause vasodilation and
bradycardia, which result from the stimulation of the 5HT3 receptors in the vagal nerve
endings (Owczuk et al., 2008).
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Owczuk et al. (2008) implemented a study to validate their hypothesis that
blocking type three serotonin receptors by introducing ondansetron intravenously would
reduce hypotension and bradycardia induced by spinal anesthesia. Seventy-one adult
pregnant patients participated in the study. Patients were randomly placed into two
groups. The ondansetron group contained 36 patients who received 8 mg of ondansetron
diluted in 10 ml normal saline. The placebo group included 35 patients who were
administered 10 ml of normal saline. Baseline measurements were obtained five minutes
prior to the spinal anesthetic and every five minutes throughout the procedure. There was
a decrease in the mean arterial pressure (MAP), systolic arterial pressure (SAP), and
diastolic arterial pressure (DAP) in both groups when compared to the baseline
measurements with the heart rate (HR) values remaining unchanged. The ondansetron
group showed a higher SAP when measurements were taken at the 10, 15 and 20-minute
marks. The MAP, DAP, and HR had no significant changes in the two groups at these
minute marks. A SAP drop below 90 mmHg was detected in 7 patients in the placebo
group and 1 patient in the ondansetron group (20% vs. 2.8%) this difference was
statistically significant ( p=.028) (Owczuk et al., 2008). The study concluded there was
no definite evidence that the ondansetron had more advantages than administration of
vasopressors, but its use may be more beneficial for particular groups of patients. One
population of patients is pregnant women, in which the administration of vasopressors
can have adverse effects on uterine blood flow, and may not be the optimal choice.
In a study conducted by Sahoo, SenDasgupta, Goswami, and Hazra (2012) the
authors hypothesized that spinal induced hypotension and bradycardia could be
minimized with ondansetron in non-laboring obstetric patients undergoing a cesarean
9

section. This study consisted of 52 patients scheduled for cesarean sections who were
randomly placed into two groups. Group O consisted of 26 patients receiving 4 mg of
ondansetron. Group S consisted of 26 patients receiving 10 ml normal saline. Heart rate,
blood pressure, and vasopressor use were measured with each group. Decreases in mean
arterial pressure were significantly lower in Group O. Patients in Group O required
significantly less vasopressor (p=0.009) (Sahoo et al., 2012). The use of ephedrine and
the incidence of nausea were significantly decreased with the administration of
ondansetron. The study concluded that administration of ondansetron 4 mg five minutes
prior to the spinal anesthetic reduces hypotension and vasopressor use in patients
undergoing a cesarean section.
Wang et al. (2014b) investigated the effects of administering ondansetron prior to
spinal anesthesia by coloading crystalloid infusion after the administration with cesarean
delivery. The research extended previous studies that investigated the effect of
preloading with crystalloid on hypotension. Though there are benefits to this method,
researchers concluded that delaying the spinal anesthesia for the nurse to deliver a fixed
amount of crystalloid was not the best option.
Wang et al. (2014b) continued their investigation by administering ondansetron
prior to the cesarean sections, which would not require a delay in onset of anesthesia.
These authors hypothesized that administering ondansetron prior to the spinal and
crystalloid after the spinal would decrease the incidence of hypotension. The study
consisted of 62 women taking part in an elective cesarean section. The women were
placed into two randomly selected groups. The group receiving ondansetron had a
significantly lower incidence of hypotension and nausea than the placebo group (p=0.011
10

vs. 0.004). The frequency of decreasing mean arterial pressure and systolic pressure were
also lower in the group receiving ondansetron compared to the placebo group (p=0.008
vs. 0.025). This group also required less phenylephrine administration throughout the
case. The authors concluded the method used helped to significantly reduce maternal
hypotension and nausea, and reduced the amount of vasoconstrictors used during the
case.
While studies have shown the benefits of using ondansetron on maternal
hypotension when administering spinal anesthesia, one drawback has been that the
different amounts of the drug were not fully investigated. In Wang et al. (2014a) a dosedependent study was set up to determine the optimal dose for ondansetron. One hundred
and fifty women were divided up into five groups (n=150). The groups consisted of a
control placebo and administration groups receiving 2mg, 4mg, 6mg and 8 mg of
ondansetron. The group 4mg and 6mg showed a reduced incidence of maternal
hypotension compared to other groups (p≤0.05). Minimal changes from baseline in the
mean arterial pressure, systolic blood pressure, and diastolic pressure appeared in these
two groups. The researchers concluded that while both doses provided the beneficial
results, administration of 4mg ondansetron is the best option. Administering 6mg or
greater of ondansetron is related to lactate acidosis in the fetus. The administration of
less than 4mg ondansetron failed to show a reduced incidence of maternal hypotension.
Four milligrams ondansetron was determined to be the optimal dose because of the dose
ability to prevent maternal hypotension, decrease nausea and the reduced need for
vasoconstrictors (Wang et al., 2014a).
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The use of ondansetron for maternal hypotension is considered to be a newer
intervention that is not entirely understood. Ortiz-Gomez et al. (2014) performed a
double-blind, randomized study to observe the effects of ondansetron and determine the
optimal dose. One hundred twenty-eight women undergoing elective cesarean sections
receiving spinal anesthesia were involved in the study. The women were randomly
placed into four groups (n=32) and received either a placebo or 2 mg, 4 mg, 8 mg
ondansetron dosages prior to spinal anesthesia. The authors concluded there were no
differences in the number of patients with hypotension: 14 patients (43.7%) in the
placebo group, 17 (53.1%) in the 2 mg group, 18 (56.2%) in the 4 mg group, and 17
(53.1%) in the group receiving 8 mg ondansetron (p=0.77). There were also no
differences found in the groups of patients requiring vasoconstrictors. The study did not
support administration of ondansetron prior to spinal anesthesia to reduce maternal
hypotension. The authors concluded that the findings showed there was little effect on
the incidence of hypotension from administration of ondansetron in parturients
undergoing spinal aesthesia. This effect might be due to differences in a particular
population, sample size, study design, and anesthetic technique.
Farmawy and Rashad (2013), performed a study to observe the effects of giving
ondansetron or granisetron to patients undergoing spinal anesthesia for their cesarean
section. The authors investigated the effect of hypotension related to spinal anesthesia by
observing the effects of the patient’s hemodynamics and sensory blockade. Sixty women
undergoing elective cesarean section were divided into three groups (n=20). The first
group, labeled O, had an injection of 4 mg of ondansetron mixed with 10 ml of normal
saline. The second group, labeled G, had an injection of 1 mg granisetron mixed with 10
12

ml of normal saline, and the third group, labeled S, had an injection of 10 ml of normal
saline. The results of the study concluded ondansetron was most effective in decreasing
hypotension related to spinal anesthesia with lower vasopressor use (p< 0.05) and
granisetron was more efficient in allowing the motor functions to come back sooner (p
<0.05). There was also a significant decrease in nausea in the groups administered
ondansetron and granisetron (p = 0.008).
The advancement of surgery and medicine has brought about new studies that will
help in increasing positive outcomes of patients. The articles in this literature review had
varying results on the administration of ondansetron to help decrease the incidence of
hypotension associated with spinal anesthesia. Though the authors provided sufficient
evidence to support the use of ondansetron, more studies and evidence need to be
accumulated before making a final decision. Safety and efficiency are the main
objectives when caring for our patients. Ondansetron has many beneficial uses in the
clinical setting, to be able to use it to help prevent spinal anesthesia induced hypotension,
as well as nausea and vomiting will be an added benefit. A medication having multiple
benefits and few disadvantages will ensure the patient receives the best care possible.
Within this doctoral project’s clinical site, some providers administer ondansetron
prior to spinal anesthesia and other providers do not. The medical field is ever changing,
and advances are being made on a daily basis. Healthcare providers’ single goal is to
provide the safest and most efficient care to patients. In providing care to women
receiving spinal anesthesia for a cesarean section, there are many potential problems that
need to be addressed. One of the main side effects of spinal anesthesia is hypotension
(Farmawy & Rashad, 2013). This side effect can cause many problems for the mother
13

and the neonate that has yet to be born. The purposes of this doctoral project are to
determine if ondansetron, a 5HT3 antagonist, helps reduce the hypotension associated
with spinal anesthesia in women having a cesarean section, also if ondansetron use
reduces the administration of vasopressors. These clinical questions will be answered
using a retrospective chart review. In the sections that follow the method/data collection
and analysis of the data will be discussed.
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CHAPTER III - METHODOLOGY
The retrospective chart analysis took place at a hospital in the Southeastern
United States. The facility has 512-inpatient beds. Patient information and recordkeeping is accomplished by using EPIC software. Inclusion criteria consists of patients
receiving spinal anesthesia for elective cesarean sections, ages 20-40 years, ondansetron
only given prior to spinal anesthesia, ondansetron given in ten minutes or less before
spinal anesthesia and met the American Society of Anesthesiologist’s (ASA) patient
status classification I or II. Exclusion criteria includes patients presenting for cesarean
section with epidural due to failure to progress, ASA patient status classification III, IV
or V, emergent cesarean sections, multiple parities (twins/triplets), > 1,000 ml blood loss,
> 6 mg ondansetron administered, patients presenting with a cardiac history (coronary
artery disease, myocardial infarction, congestive heart failure, murmur, mitral valve
prolapse/regurgitation, dysrhythmias, aortic stenosis/regurgitation), patients taking blood
pressure medication and patients presenting with preeclampsia. After examining all data,
a final inclusive data set was obtained. A sample size calculator determined the sample
size, and the confidence level and confidence interval needed to produce a significant
result. According to G power calculator with using a Chi square test the sample size will
be 145, effect size 0.3 (medium), beta to alpha ratio .95,critical x2= 3.841458 and degrees
of freedom 1. A Chi-Square test can determine if there is a significant relationship
between two variables, those variables being the use of ondansetron and the incidence of
hypotension after spinal anesthesia in women undergoing elective cesarean sections and
the use of ondansetron and the administration of vasopressors. The independent variable
consists of the usage of ondansetron and the non-usage of ondansetron. Dependent
15

variable are if hypotension does occur or does not occur, and if vasopressors are given or
not.
Procedures/Methods
After IRB and hospital approval (See Appendix F), access to EPIC computer
charting system was commenced. Patients at this time were de-identified. De-identifying
the data was accomplished by deleting the patient identification number and substituting
the number with a researcher generated unique identifier. A data collection instrument
(DCI) was used to record patient data. (See Appendix C). The data collection instrument
included subject number, age, ASA classification, diagnosis, previous cesarean sections,
parity, hypotensive episodes, and administration of vasopressors. The hypotensive
occurrences were defined as having more than a 20% decrease in blood pressure from
baseline blood pressure prior to spinal anesthesia.
Analysis
Retrospective results and a presentation were compiled using the information/data
collection from the literature review and chart analyis. This presentation was presented
to the anesthesia providers at the facility where data were collected. Data hygiene and
unvariate analysis was used to look for outliers, miskeyed data and audits between data
collection instrument (DCI) and every tenth subject ID. A Chi square analysis was used
to analyze data between the independent and dependent variables stated earlier in the
methodology section. All data collected were used to inform fellow anesthesia providers
whether ondansetron reduced the incidence of low blood pressure in this hospital’s
elective cesarean section patients, and also whether the use of ondansetron reduced the
use of vasopressors.
16

CHAPTER IV – RESULTS
This DNP project determined if administration of ondansetron prior to spinal
anesthesia in elective cesarean section patients reduces hypotension and the use of
vasopressors. Variables examined were use of ondansetron, administration ten minutes
or less prior to spinal anesthesia and usage of vasopressors up until the birth of the baby.
A comprehensive literature review was conducted and results from the retrospective chart
analysis were compiled within this doctoral project.
This project utilized the Chi Square test to assess the relationships in receiving
ondansetron prior to spinal anesthesia and not receiving ondansetron prior to spinal
anesthesia and the effect this drug has on reducing hypotension and on the use of
vasopressors. The Chi Square test was executed by using SPSS (Statistical Package for
the Social Sciences) by the researcher. Results were considered significant if the p value
was equal to or less than .05.
Discussion of Results
There were 812 patient charts reviewed. Of the 812 charts, 57 met the inclusion
criteria of receiving ondansetron ten minutes or less prior to spinal anesthesia, were
between the ages of 20-40, and were an ASA class of I or II. Out of the 812 charts, 57
were also chosen that met all inclusion criteria except they did not receive ondansetron
prior to spinal anesthesia, these charts were used to compare blood pressure values and
vasopressor use to the prior 57 charts chosen. The 57 charts who did not receive
ondansetron prior to spinal anesthesia were chosen on a first come, first serve basis. The
first 57 available charts that met the criteria were used. Of the 114 charts used the
minimum age was 20, maximum age of 39, with a mean age of 29. The minimum parity
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was 0, the maximum parity was 10, with a mean parity of 1. There were 7 patients who
fell into the ASA I class, with 107 patients in ASA II class.
A Chi Square test was conducted to examine hypotension in patients who did and
did not receive ondansetron prior to spinal anesthesia in elective cesarean sections
patients. The test determined there was not a significant association between the
hypotension group and whether or not they used ondansetron, N=114, df=1, x2 (1) = .035,
p= .851 (Tables 1 & 2). These results show there is no significant benefit of using
ondansetron prior to spinal anesthesia to help reduce hypotension. The second Chi
Square test was done to investigate if less vasopressors were used up until the baby was
born on those who received ondansetron. There was a significant association between
vasopressor use and whether or not they used ondansetron, N=114, df=1, x2(1) = 6.437,
p= .011 (Tables 3 & 4).
Table 1 Ondansetron and Hypotension Crosstabulation
Hypotension

25

No
Hypotension
32

57

25.5

31.5

57.0

26

31

57

Expected
Count
Count

25.5

31.5

57.0

51

63

114

Expected
Count

51.0

63.0

114.0

Hypotension
Treatment

Ondansetron
Administered

Count
Expected
Count

No
Ondansetron
Administered
Total

Total

Count
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Table 2 Pearson Chi-Square Test Ondansetron and Hypotension

Pearson Chi-Square

Value

df

.035

1

Asymptotic
Significance (2sided)
.851

Table 3 Ondansetron and Vasopressor Crosstabulation

Treatment

Vasopressor
Some
No
Vasopressor
Vasopressor
30
27

Count
Ondansetron
Administered

Expected
Count
Count

No Ondansetron
Administered
Total

Expected
Count
Count
Expected
Count

Total

57

36.5

20.5

57.0

43

14

57

36.5

20.5

57.0

73

41

114

73.0

41.0

114.0

Table 4 Pearson Chi-Square Test Ondansetron and Vasopressor

Pearson Chi-Square

Value

df

6.437

1
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Asymptotic
Significance (2sided)
.011

CHAPTER V – SUMMARY
The main goals of this retrospective chart analysis were to show whether the
administration of ondansetron prior to spinal anesthesia would help reduce hypotension,
or the use of vasopressors After performing Chi Square tests through SPSS, it was
determined the use of ondansetron was not significant in reducing hypotension related to
spinal anesthesia. However, it was found that patients receiving ondansetron prior to
spinal anesthesia were requiring less vasopressor use during their cesarean sections.
Limitations
There were limitations to this doctoral project. If I had expanded inclusion
criteria by increasing the amount of time prior to spinal anesthesia that ondansetron was
given it may have increased the numbers of patients available for the study, thus
providing more charts to review and increasing the study’s power. Increasing the sample
size could have been what the study needed to meet the power analysis and show a
significance between ondansetron usage and reduction in hypotension. Increasing the
amount of time prior to the spinal anesthetic could have also been beneficial in that it
would allow the medication longer to take effect and could have possibly made more of a
change in hypotension. Use of a randomized sample could have been used to reduce bias
when performing a retrospective chart review. Another possible limitation to this project
is the fact that the medication could have been given outside the measurement period,
which in turn would skew the study’s results.
Barriers
One of the main barriers to this project are the multiple definitions in hypotension. The
literature states “hypotension being defined as a blood pressure of less than 20% of the
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baseline or preoperative blood pressure” (Nagelhout & Plaus, 2014, p. 1229). Literature
also states that the practitioner should look at clinical signs, such as, nausea and loss of
consciousness, and not just look at numeric signs of hypotension (Nagelhout & Plaus,
2014). Clinically most practitioners will treat a systolic blood pressure less than 100
regardless if it is 20% of baseline or not. This causes a barrier to the study, because some
practitioners may be treating the blood pressure with vasopressors before a 20% drop is
ever detected, they may just be treating based off of clinical signs.
Future Directions
This doctoral project can definitely be expanded in the future. Taking into
consideration the limitations and possible changes that can be made to the project there is
room to show more possible benefits of using this medication prior to spinal anesthesia.
A closer examination of the decreased usage of vasopressors could be a major benefit in
the use of ondansetron and bring about a possible practice change.
Conclusion
Spinal anesthesia is the most common anesthetic used when performing elective
cesarean sections. Hypotension is one of the most common side effects experienced after
performing spinal anesthesia. This side effect can be harmful to mother and the unborn
child if gone untreated. This doctoral project was performed to look at administering
ondansetron prior to spinal anesthesia in elective cesarean section patients in helping to
reduce hypotension. In trying to determine if ondansetron will help in reducing the
incidence of hypotension with spinal anesthesia associated with cesarean sections,
scholarly databases and peer-reviewed articles were used to obtain the evidence. A
spread matrix was constructed to bring together all information discussed in the literature.
21

The project results showed that there was no significant association between ondansetron
and hypotension, but did show a significant association between ondansetron and
decreased vasopressor use in this clinical setting. Decreasing the use of vasopressors
helps in reducing the chance of causing issues to the unborn child and decreases the
amount of medications being given to mother and baby before birth. Ondansetron is a
medication that is typically given at some point during the cesarean section to help with
nausea. This project has shown that giving it prior to spinal anesthesia can help decrease
medication usage and can in turn still help with the unwanted nausea during the case.
Information from this study was compiled and presented to anesthesia providers at a local
hospital. There was a definite interest in the findings and a possible practice change
indicated verbally among some of the providers. As with any new finding and
educational material, there are still some who are hesitant to change, especially when
dealing with an unborn child. Hopefully the disseminated information will be passed on
so providers will see the benefits of using ondansetron in their practice.
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APPENDIX A – Literature Matrix
Author

Rashad and Farmawy

Wang, M. et al.

Owczuk et al.

Year

Design

2013

Quantitative

2014

Dose-dependent
study

2008

Double-blind,
placebo controlled
study

Framework

None

Sample

None

60 pregnant woman (20 per
group), ASA I-II, aged 20-40,
scheduled for elective
cesarean

None

150 pregnant women (30 per
group), ASA I-II, aged 18-35,
37-42 weeks of gestation

71 individuals, 2 groups (36
in ondansetron group, 35 in
placebo group), ASA I-II,
age 20-70
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Findings
1. 4mg ondansetron
significantly decreased
hypotension and vasopressor
use; IV granisetron induced
faster sensory recovery
2. MAP were significantly
lower in group O (n=20,
P <.05)than groups G (n=20,
P <.05) and S (n=20, P <.05)
with lower vasopressor use
3. Faster sensory recovery in
group G (n=20, P <.05) than
groups O (n=20, P <.05) and S
(n=20, P <.05)
4. Significant decrease in
nausea in groups O (n=20,
P =0.008) and G (n=20,
P =0.008) than S (n=20,
P =.008)
1. Compared to group
S(placebo), the incidence of
maternal hypotension was
sigificantly lower in groups
O4 (n=30, P <0.05) and O6
(n=30, P <0.05).
2.The umbilical venous pH
was significantly higher in O4
(n=30, P <0.05, O6 (n=30,
P <0.05), and O8 (n=30,
P <0.05); and the bicarbonate
and base excess in
extracellular fluid were
significantly lower in groups
O6 (n=30, P <0.05) and O8
(n=30, P <0.05).
3. Minimal changes of
systolic blood pressure,
diastolic blood pressure, and
mean arterial blood pressure
were observed in group O4
(n=30, P <0.05)
1. Decreases in mean,
systolic, and diastolic arterial
pressure as well as in heart
rate, compared with baseline
valuesvalues were observed
in both groups.
2. Minimal systolic and mean
blood pressure values
obtained over a 20-minute
observation period were
significantly higher in the
ondansetron group.
3. There were no significant
differences in diastolic blood
pressure and heart rate values
between the groups.

Notes

Sahoo et al.

2011

Double-blind,
randomized, placebocontrolled study
None

Ortiz-Gomez et al.

2014

Double-blind,
randomized, placebocontrolled trial
None

Wang, Q. et al.

2014

Quantitative

None

52 pregnant women having a
cesarean section(Group
O=26, Group S=26), ASA I,
age 20-40

1. Decreases in mean arterial
pressure were significantly
lower in Group O than Group
S.
2. Patients in Group O (n=26)
required significantly less
vasopressor (P =0.009) and
had significantly lower
inceidences of nausea and
vomiting (P=0.049).

1. There were no differences
in the number of patients with
hypotension in the placebo
(43.8%, n=32, P =0.77) and
128 healthy pregnant women ondansetron 2mg (53.1%,
having a cesarean section, 4 n=32, P =0.77), 4 mg (56.3%,
groups ( n=32 per group),
n=32, P =0.77), and 8 mg
ASA I, age 20-45
(53.1%, n=32, P =0.77).
1.Maternal hypotension and
nausea were significantly
66 women having a cesarean lower in ondansetron treated
section, 2 groups (n=33 per patients (n=33, P =0.011)
group),ASA I-II, age 18-35, versus placebo (n=33,
37 to 42 weeks gestation
P =0.004).
2. Decreases in maternal
sustolic and mean arterial
pressures were significantly
lower in ondansetron treated
patients (n=33, P =0.008)
versus placebo (n=33,
P =0.025), with less requirment
of pehnyephrine
administration compared with
controls (P =0.029).
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APPENDIX B – Doctor of Nursing Essentials

DNP ESSENTIALS
Essentials I- Scientific underpinnings for
practice
Essentials II- Organizational and systems
leadership for quality improvement and
systems thinking

Essentials III- Clinical scholarship and
analytical methods for evidence based practice
Essentials IV- Information systems or
technology and patient care technology for the
improvement and transformation of healthcare

Essentials V- Healthcare policy for advocacy
in healthcare

Essentials VI- Interprofessional collaboration
for improving patient and population health
outcomes

Essentials VII- Clinical prevention and
population health for improving the nation’s
health

Essentials VIII- Advanced nursing practice

CLINICAL IMPLICATIONS
Using the most up to date and safest evidence
to prevent injury to the patient while using
spinal anesthesia
The administration of ondansetron may reduce
hypotension related to spinal anesthesia,
without the negative effects of other
medications. This in turn will bring about
implementation of policies to improve patient
outcomes
Using a Chi square test to analyze data
between two groups, involving independent
and dependent variables
Performing a retrospective chart review patient
data will be removed from their electronic
medical record and protected avoid ethic/legal
issues. Electrical databases will be used for
review of literature and to obtain information
regarding ondansetron and spina anesthesia on
cesarean section patients
If information from this doctoral project
indicates ondansetron does help in the
reduction of hypotension related to spinal
anesthesia in cesarean section patients, then a
practice change can be implemented to provide
better patient safety and increase overall
patient satisfaction
Collaboration between anesthesia providers is
pivotal to bringing about a practice change.
Each provider has vital information and
suggestions that can help bring about a change
and help in providing the safest care to the
patient population. Collaboration between the
EPIC staff and the researcher in being able to
gather information needed for this study.
The use of such medications as ephedrine
though effective, can cause decreased
uteroplacental perfusion. This project will
evaluate using ondansetron in helping reduce
the incidence of hypotension to help in either
decreasing or alleviating the use of pressors
such as ephedrine all together in the pregnant
patient population, which in turn would
improve patient outcomes
Applying evidence based practice and
advanced clinical knowledge to maintain and
provide the safest care to patients receiving
anesthesia
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APPENDIX C –Data Collection Table

Age

Subject1
Subject2
Subject3
Subject4
Subject5

ASA

Diagnosis

Elective
C-section

Parity

Hypotension Vasopressor Ondansetron Ondansetron
Use
Use Prior to
Given 10
Spinal
min or Less
Before
Spinal

26

APPENDIX D - Logic Model

Assumptions
•Reducing the
incidence of
hypotension related
to spinal anesthesia
is important to
healthcare
personnel
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•Preventing
unwanted side
effects and issues
with hypotension
related to spinal
anesthesia is
important to
healthacre workers
and patients

Resources
•Research Articles
•Time needed to
review articles and
literarure reviews
•Time needed to
comb through
patient information
to include in data
collection

Activities

Outputs

•Use of literature
reviews involving
evidence based
practices

•Educational material

•Selecting articles
best suited for the
project based on
evidence based
practice and
incidence of
hypotension in
cesarean section
patients receiving
spinal anesthesia

•Literature review

•Reviewing and
assessing records

•White paper
proposal

Outcomes
•Initial
•Decrease incidence of
hypotension
•Provide knowledge to
staff about the use of
ondansetron

•Intermediate
•Shorter recovery
time/hospital stay
•Decreased incidence of
syncope,
nausea/vomitting, and
heart related issues

•Long-Term
•Decreased incidence of
ischemia
•Decreased costs for
long term care
•Changing of hospital
policy regarding
medition used for
spinal anesthesia

APPENDIX E - SWOT
Strengths

Weaknesses



No additional costs or extra work for the clinical site



Inadequate documentation by the provider



Retrospective chart review



Variables cannot be controlled in a retrospective
chart analysis

Opportunities



Threats
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Change in practice for the facility



Ondansetron having no effect on decreasing
hypotension in patient population

Increases patient satisfaction scores and overall
experience



Anesthesia providers unwillingness for practice
change

APPENDIX F – IRB Letters of Approval
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